ZVRA · Forms 3, 4, 5
Insider trades at ZEVRA THERAPEUTICS, INC.
1 insider sold $225K of ZEVRA THERAPEUTICS, INC. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for ZEVRA THERAPEUTICS, INC. (ZVRA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Neil F. McFarlane | President and CEO | Sell (10b5-1 plan) | 20,000 | $11.25 | $225K | Form 4 | |
| Neil F. McFarlane | President and CEO | Option exercise | 50,000 | Form 4 | |||
| Rahsaan Thompson | Chief Legal & Compliance | Sell (10b5-1 plan) | 42,666 | $11.13 | $475K | Form 4 | |
| Corey Michael Watton | Director | Option exercise | 12,300 | $4.97 | $61K | Form 4 | |
| Corey Michael Watton | Director | Sell | 12,300 | $11.25 | $138K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.